Large artery wall thickening and its determinants under antihypertensive treatment: The IMT-INSIGHT Study

Journal of Hypertension

Volumn 22, Issue 1, 2004, Pages 137-143

  Gariepy, Jerome ^a   Simon, Alain ^a,b   Chironi, Gilles ^a   Moyse, Dominique ^a   Levenson, Jaime ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL BROUSSAIS   (France)

Author keywords

Carotid arteries; Drugs; Hypertension; Hypertrophy; Ultrasonics

Indexed keywords

AMILORIDE PLUS HYDROCHLOROTHIAZIDE; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; NIFEDIPINE;

ADULT; AGED; ARTERY WALL; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; FEMALE; HISTOGRAM; HUMAN; HYPERTENSION; INTIMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TUNICA MEDIA;

EID: 1442299092     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200401000-00023     Document Type: Article

References (14)

1. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002; 20:159-169.
2. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaboration Research Group. N Engl J Med 1999; 340:14-22.
3. Bots ML, Hoez AW, Koudstaal PJ, Hofman A, Grobbee DF. Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study. Circulation 1997; 96:1432-7.
4. Zanchetti A, Rosei EA, Dal Palu C, Leonetti G, Magnani B, Pessina A, for the Verapamil in Hypertension and Atherosclerosis Study (VHAS) Investigators. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness. J Hypertens 1998; 16:1667-1676.
5. Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GB, Niller RE, et al., for the Prevent Investigators. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation 2000; 102:1503-1510.
6. Lonn EM, Yusuf S, Dzvik V, Doris C, Yi Q, Smith S, et al. for the SECURE Investigators. Effects of ramipril and vitamin E on atherosclerosis. The study to evaluate ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 2001; 103:919-925.
7. Simon A, Gariepy J, Moyse D, Levenson J. Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes. Circulation 2001; 103:2949-2954.
8. Zanchetti A, Bond MG, Henning M, Neiss A, Mancia G, Dal Palu C, et al. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation 2002; 106:2422-2427.
9. Brown MJ, Palmer CR, Castaigne A, De Leeuw PW, Mancia G, Rosenthal T, et al. Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS Study: Intervention as a goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356:366-372.
10. Smilde TJ, Van Wissen S, Wollersheim H, Trip MD, Kastelein JJ, Stalenhoef AF. Effect of aggresive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomized, double blind trial. Lancet 2001; 357:577-581.
11. Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palu C, et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens 1998; 16:949-961.
12. Munro E, Patel M, Chan P, Betteridge L, Gallagher K, Schachter M, et al. Effect of calcium channel blockers on the growth of human vascular smooth cell derived from saphenous vein and vascular graft stenosis. J Cardiovasc Pharmacol 1994; 23:779-784.
13. Jackson CL, Bush RC, Bowyer DE. Mechanism of antiatherogenic action of calcium antagonists. Atherosclerosis 1989; 80:17-26.
14. Crouse JR, Goldbourt U, Evans G, Pinsky J, Shawett AR, Sorlie P, et al. Arterial enlargement in the atherosclerosis risk in communities (ARIC) cohort. In vivo quantification of carotid arterial enlargement. Stroke 1994; 25:1354-1359.